PLT 1.28% 79.0¢ plenti group limited

specialist sevical cancer, page-9

  1. 880 Posts.
    re cerviscreen. of course there have been no write ups in journals.

    Cerviscreen is largely a consumer product opportunity rather than a medical breakthrough.

    PLT has to pull together a number of pieces of the pathology value chain to offer a consumer-friendly methodology for taking & processing samples and delivering pathology results to consumers.

    Having obtained rights to the GeneSwab self sampler, the rest is a logistics / negotiation / marketing challenge rather than something that you would expect to see in a medical journal.

    And as for doctor awareness in St Kilda road? The product hasn't been launched in Australia to my knowledge, so there is absolutely no reason for the doctor to know about it.

    If anyone anywhere has heard of cerviscreen they would be in China. And i don't even know if the integrated product has been launched there yet? suspect not quite.

    back to sleep.
 
watchlist Created with Sketch. Add PLT (ASX) to my watchlist
(20min delay)
Last
79.0¢
Change
0.010(1.28%)
Mkt cap ! $138.5M
Open High Low Value Volume
78.5¢ 79.5¢ 78.5¢ $20.63K 26.08K

Buyers (Bids)

No. Vol. Price($)
1 5847 79.0¢
 

Sellers (Offers)

Price($) Vol. No.
79.5¢ 28391 1
View Market Depth
Last trade - 15.58pm 28/06/2024 (20 minute delay) ?
PLT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.